Allbirds
NASDAQ:BIRDAllbirds, Inc. manufactures and sells footwear and apparel products for men and women in the United States and internationally. The company offers a range of lifestyle and performance shoes; and apparel, including classic tees and sweats, socks, and underwear. It sells its products through its retail stores, as well as online. The company was formerly known as Bozz, Inc. and changed its name to Allbirds, Inc. in December 2015. Allbirds, Inc. was incorporated in 2015 and is headquartered in San Francisco, California.
Century Communities
NYSE:CCSCentury Communities, Inc., together with its subsidiaries, engages in the design, development, construction, marketing, and sale of single-family attached and detached homes. It is also involved in the entitlement and development of the underlying land; and provision of mortgage, title, and insurance services to its homebuyers. The company offers homes under the Century Communities and Century Complete brands. It sells homes through its sales representatives, retail studios, and internet, as well as through independent real estate brokers in 18 states in the United States. Century Communities, Inc. was founded in 2002 and is headquartered in Greenwood Village, Colorado.
Petrominerals
OTCMKTS:PTROPetrominerals Corporation engages in the exploration, drilling, and production of oil and gas; and other oil industry-related businesses. It owns interests in oil producing properties in southern California. The company has a 53% working interest in the Castaic Hills Unit; a 100% working interest in a single oil well; and a 83.3% working interest in two oil wells in the Hasley Canyon field. Its properties are located in Santa Clarita, California. The company's net production of oil and gas was approximately 8 million barrels, as of December 31, 2003. It had approximately 23 gross oil and gas producing wells, as of the above date. Petrominerals Corporation was founded in 1966 and is based in Ventura, California.
Terns Pharmaceuticals
NASDAQ:TERNTerns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology, metabolic dysfunction-associated steatohepatitis (MASH), and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of MASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.
